Once again, Anteo's snatched defeat from the jaws of victory.
I believed they might actually come good and submit their COVID test for common list approval this quarter, but sadly that's not the case and they're now chasing another rainbow.
We now look to the energy division for any immediate hope of salvation.
Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-28
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.003(10.3%) |
Mkt cap ! $64.73M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.6¢ | $209.8K | 7.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 592714 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 269442 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |